Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | A$134.34B | 32.8x | 1.69 | A$277.01 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
Resmed DRC | Sydney | Healthcare | Healthcare Equipment & Supplies | A$52.55B | 30.8x | 1.47 | A$36.04 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Pro Medicus Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | A$21.88B | 263.5x | 7.08 | A$209.86 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.4% Downside | Upgrade to Pro+ | |
Fisher&Paykel Healthcare | Sydney | Healthcare | Healthcare Equipment & Supplies | A$19.69B | 162.8x | -3.51 | A$33.51 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.7% Upside | Upgrade to Pro+ | |
Cochlear | Sydney | Healthcare | Healthcare Equipment & Supplies | A$19.31B | 54.2x | 2.82 | A$294.94 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
Sonic Healthcare | Sydney | Healthcare | Healthcare Providers & Services | A$12.42B | 24.2x | -0.98 | A$25.89 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.6% Upside | Upgrade to Pro+ | |
Ramsay Health Care Pref | Sydney | Healthcare | Healthcare Providers & Services | A$8.58B | 9.8x | A$105 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ramsay Health Care | Sydney | Healthcare | Healthcare Providers & Services | A$8.58B | 9.8x | 0.17 | A$37.36 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.1% Upside | Upgrade to Pro+ | |
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$7.69B | 151.2x | 0.79 | A$22.90 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.1% Upside | Upgrade to Pro+ | |
Ebos | Sydney | Healthcare | Pharmaceuticals | A$6.51B | 23.6x | 3.83 | A$33.57 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.5% Upside | Upgrade to Pro+ | |
Ansell | Sydney | Healthcare | Healthcare Equipment & Supplies | A$4.67B | 35x | -0.82 | A$32.28 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.3% Upside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | A$3.73B | -1,200x | 11.3 | A$2.39 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.3% Downside | Upgrade to Pro+ | |
Summerset Group | Sydney | Healthcare | Healthcare Providers & Services | A$2.82B | 7.6x | 0.15 | A$11.93 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$2.27B | -44.3x | 0.86 | A$7.14 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.8% Upside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Pharmaceuticals | A$2.13B | 18.1x | 0.16 | A$16.71 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regis Healthcare Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$1.89B | -88.7x | -3.69 | A$6.26 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.9% Upside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | A$1.76B | -11.3x | -0.78 | A$1.57 | -11.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.3% Downside | Upgrade to Pro+ | |
Polynovo | Sydney | Healthcare | Healthcare Equipment & Supplies | A$1.41B | 256.9x | 1.33 | A$2.04 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.5% Upside | Upgrade to Pro+ | |
Nanosonics | Sydney | Healthcare | Healthcare Equipment & Supplies | A$1.02B | 77.7x | -2.15 | A$3.37 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.7% Upside | Upgrade to Pro+ | |
Primary Health Care | Sydney | Healthcare | Healthcare Providers & Services | A$958.50M | -1.3x | 0.04 | A$1.34 | -16% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.8% Upside | Upgrade to Pro+ | |
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | A$800.21M | -1.2x | 0.42 | A$0.66 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Paragon Care Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | A$769.72M | 52.2x | -2.71 | A$0.47 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Integral Diagnostics Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$720.46M | -11.8x | 0.03 | A$3.08 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.7% Upside | Upgrade to Pro+ | |
Australian Clinical Labs | Sydney | Healthcare | Healthcare Providers & Services | A$707.64M | 28.2x | -0.92 | A$3.42 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.1% Upside | Upgrade to Pro+ | |
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$666.79M | 18.5x | 1.06 | A$13.28 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | A$572.50M | -35.3x | 2.71 | A$0.32 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oceania Healthcare | Sydney | Healthcare | Healthcare Providers & Services | A$477.99M | 16.5x | 0.18 | A$0.66 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | A$477.10M | -9.1x | -0.48 | A$0.33 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Monash IVF Group Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$438.34M | -66.1x | 0.54 | A$1.13 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Capitol Health | Sydney | Healthcare | Healthcare Providers & Services | A$404.92M | -27.1x | 1.06 | A$0.38 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15% Downside | Upgrade to Pro+ |